Edwards Lifesciences Corporation (EW): Price and Financial Metrics


Edwards Lifesciences Corporation (EW)

Today's Latest Price: $189.07 USD

4.21 (2.28%)

Updated Apr 3 12:00am

Add EW to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

EW Stock Summary

  • With a market capitalization of $38,664,673,446, Edwards Lifesciences Corp has a greater market value than 96.26% of US stocks.
  • The price/operating cash flow metric for Edwards Lifesciences Corp is higher than 92.58% of stocks in our set with a positive cash flow.
  • With a price/sales ratio of 8.89, Edwards Lifesciences Corp has a higher such ratio than 90.85% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Edwards Lifesciences Corp, a group of peers worth examining would be ATVI, BIIB, PHG, DE, and BSX.
  • EW's SEC filings can be seen here. And to visit Edwards Lifesciences Corp's official web site, go to www.edwards.com.
EW Daily Price Range
EW 52-Week Price Range

EW Stock Price Chart More Charts


EW Price/Volume Stats

Current price $189.07 52-week high $247.64
Prev. close $184.86 52-week low $154.52
Day low $182.27 Volume 1,979,800
Day high $191.70 Avg. volume 1,765,271
50-day MA $208.60 Dividend yield N/A
200-day MA $218.83 Market Cap 39.54B

Edwards Lifesciences Corporation (EW) Company Bio


Edwards Lifesciences provides products and technologies to treat structural heart disease and critically ill patients worldwide. It is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The company was founded in 1999 and is based in Irvine, California.

EW Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$189.07$33.27-82%

We started the process of determining a valid price forecast for Edwards Lifesciences Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Edwards Lifesciences Corp ranked in the 13th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 81.83%. The most interesting components of our discounted cash flow analysis for Edwards Lifesciences Corp ended up being:

  • In the past 5.53 years, Edwards Lifesciences Corp has a compound free cash flow growth rate of -0.03%; that's better than just 22.67% of cash flow producing equities in the Healthcare sector, where it is classified.
  • The business' balance sheet suggests that 2% of the company's capital is sourced from debt; this is greater than merely 6.98% of the free cash flow producing stocks we're observing.
  • EW's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 59.47% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-82%
1%-82%
2%-82%
3%-82%
4%-82%
5%-81%

IDXX, QGEN, A, MGLN, and RVP can be thought of as valuation peers to EW, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


EW Latest News Stream


Event/TimeNews Detail
Loading, please wait...

EW Latest Social Stream


Loading social stream, please wait...

View Full EW Social Stream

EW Price Returns

1-mo -9.52%
3-mo -18.37%
6-mo -16.04%
1-year 0.40%
3-year 103.10%
5-year 170.39%
YTD -18.95%
2019 52.31%
2018 35.90%
2017 20.29%
2016 18.64%
2015 24.01%

Continue Researching EW

Here are a few links from around the web to help you further your research on Edwards Lifesciences Corp's stock as an investment opportunity:

Edwards Lifesciences Corp (EW) Stock Price | Nasdaq
Edwards Lifesciences Corp (EW) Stock Quote, History and News - Yahoo Finance
Edwards Lifesciences Corp (EW) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7117 seconds.